Publications — General

---

SCENAR-therapy applied for treatment of inflammatory processes of urogenital system and urolithiasis

SCENAR-therapist, T. I. Borovetz

During 2002 there have been treated 25 patients suffering from disorders of this kind.

12 patients had pyelonephritis (in acute condition), 6 patients suffered from chronic cystitis (4 of them in acute condition) and 7 patients had urethritis.

Before SCENAR-therapy all patients have undergone paraclinical examination. The basic course of treatment was 8 to 10 sessions. Some of the patients were prescribed phytotherapy together with SCENAR-treatment. No other methods of treatment were used. Before starting SCENAR-treatment, each patient has got familiar with what SCENAR-reactions are, so as not to consider them as negative effects of SCENAR-therapy later on.

Twice a day (in the morning and in the evening) the patients were to have their urine tested (volume, smell, transparence, colour, sediment, fatty film on the surface) during the whole course of treatment. This approach allowed the patients to be involved in the process of treatment and obviously see the changes through their urine. The objective of this visual urine control was finally seeing the normal urine analysis. Creating such motivation helps a lot in the process of SCENAR-therapy.

Urine changes (cloudy, dark, often with fetid smell and mucus) in the course of SCENAR-treatment of inflammatory processes appear on the first or second day of treatment.

After the first and second session of SCENAR-therapy the patient may experience fever and raise of temperature up to 38°C. This condition can last for 2–2.5 hours with no further worsening.

Early and pronounced SCENAR-reaction in the course of treatment of urogenital pathological conditions is a very good sign indicating quick and complete recovery process.

About 1% of the patients having urogenital pathological conditions also suffer from enuresis. Unfortunately enuresis is very difficult to treat by traditional methods, which cannot provide non-relapse condition. With SCENAR-therapy you can successfully treat this pathology.

She was regularly examined and treated for this condition in therapeutic urologic wards of Rostov-on-Don hospitals. Twice consulted specialists in Medical Institute. Seeing this produced no effect, the patient had quit visiting doctors since 1980. In May 2002 her condition worsened. Fever, no appetite, loss of weight, weakness. Enuresis condition aggravated. The patient applied for help to SCENAR-therapist. At that moment she was in grave condition: temperature of 38°C, pale skin, tallow face.

Blood count: Hb-90%, L-9100, RBC-2, Neutrophilic-12, Segmented-66, Lymphocyte-15, Monocyte-5, ESR-47.

Urine analysis revealed changes of inflammatory character.

Ultrasound examination indicated signs of pronounced pyelonephritis.

After examination the patient was conducted a course of SCENAR-therapy (10 sessions). During treatment her condition obviously was changing for the better. Enuresis was completely eliminated after 6 sessions.

Ultrasound examination conducted two weeks after the course of SCENAR-therapy indicated significant regression of pyelonephritis signs. Up to now the patient has had no complaints about her condition and no other courses of SCENAR-therapy were needed.

Methods and areas of treatment used in this case:

1. The whole vertebral column region together with trigger areas.
2. Projections of kidneys, ureters, urinary bladder and urethra.
3. Areas of biologically active points used in reflexotherapy for treatment of this condition.
4. Acting upon biologically active vegetopuncture points of kidneys, ureters and urinary bladder is obligatory.

Conclusion

While treating this pathology SCENAR allowed to quickly eliminate spastic condition of the urinary system, pain, inflammatory processes and disorders of urination.

Within this period of time there have been treated 23 patients suffering from urolithiasis. Nine of them had complications in the form of chronic pyelonephritis, the other two had hydronephrosis, and one patient had double-sided nephroptosis.

All the patients were diagnosed according to their clinical picture, anamnesis data, laboratory tests and instrumental examination:

8 patients — X-ray (general and excretory);

20 patients — ultrasound diagnostics;

1 patient — radioisotopic roentgenography.

The patients were prepared for SCENAR-therapy the same way the ones suffering from urogenital system disorders were.

Urine changes during treatment of urolithiasis conditions (without complications) occurred on the third or fourth day in the form of sediment or grains of sand.

The sediment colour was different depending on the stone type: white, yellow, orange or black. Sometimes stone excretion was accompanied by tolerable pains along ureters. The pains increased in the region of the kidneys. During stone excretion there were periods (2-4 days) of clear urine excreted. Within these periods the urine was absolutely normal and the patients had no complaints about their condition. Then the slight pains along the ureters and urine sediment occurred again. This moment should be taken care of in the course of SCENAR-treatment, so that you could properly define when the treatment should be finished.

The patients were examined again 1.5-2 months after SCENAR-therapy (except cases when the patients were indicated next examination sooner). This period was necessary for complete stone excretion, which could continue for some more time even after SCENAR-therapy has been successfully finished. The patients were warned that in case they had pains in the region of kidneys and along the ureters they should be conducted some more sessions of SCENAR-therapy. Usually 2 or 3 additional sessions are enough to eliminate this condition completely.

Examination conducted after the course of SCENAR-therapy revealed no concrements in 17 of 23 patients. Pyelonephritis signs were eliminated in 9 cases.

A patient who has been suffering from urolithiasis and pyelonephrosis felt much better after the third session of SCENAR-therapy. Ultrasound examination a month after the course of SCENAR-treatment revealed no pathological changes present before treatment.

In 6 cases the stones were not eliminated completely, but significantly decreased in size and did not disturb the patients.

After the course of SCENAR-therapy all 23 patients noticed better well-being, emotional condition, and no undue fatigue.

In May 2002 his condition worsened, kidney pains increased. The patient was put into urological ward of the hospital and had undergone complete examination.

Ultrasound examination data of May 13, 2002: both kidneys have many small stones; a concrement of 1.5x0.7 in the region of the left renal pelvis; a concrement of 0.8x0.7 in the region of the right renal pelvis; signs of pyelonephritis.

1.5 month treatment produced no effect. The patient was offered distant extracorporeal lithotripsy which he declined.

In July 2002 the patient was conducted a course of SCENAR-therapy. The first session resulted in increased urination. On the second day of treatment the urine became dark, cloudy, with thick sediment in the form of sand grains and later on — stones of millet grain size. Slight and short pains along the ureters. On the ninth day of treatment the urine became normal and the patient had no complaints about his condition.

In August the patient was conducted ultrasound examination which revealed no stones or signs of pyelonephritis.

The above examples show that with SCENAR series device you can physiologically eliminate kidney sand and stones within 10–12 sessions. In these cases SCENAR series models VX735-3.5 and PS705 were used.

Tatiana Ivanovna Borovetz
Rostov-on-Don, Russia

Translated by Elena Khatkova “LET Medical”